Jacobs DG, Brewer ML, Klein-Benheim M. Suicide assessment: an overview and recommended protocol. In: Jacobs DG, ed. The Harvard Medical School Guide
to Suicide Assessment and Intervention. San Francisco, Calif: Jossey-Bass
Publishers; 1999:3-39.
Klerman GL. Clinical epidemiology of suicide. J Clin Psychiatry.1987;48(suppl 12):33-38.
Moscicki EK. Epidemiology of suicide. In: Jacobs DG, ed. The Harvard Medical School Guide
to Suicide Assessment and Intervention. San Francisco, Calif: Jossey-Bass
Publishers; 1999:40-51.
Rosenthal RJ. Pathological gambling. Psychiatr Ann.1992;22:72-78.
Phillips DP, Welty WR, Smith MM. Elevated suicide levels associated with legalized gambling. Suicide Life Threat Behav.1997;27:373-378.
Barraclough BM, Bunch J, Nelson B, Sainsbury P. A hundred cases of suicide: clinical aspects. Br J Psychiatry.1974;125:355-373.
Fawcett JA. Assessing and treating the patient at risk for suicide. Psychiatr Ann.1995;23:244-255.
Jacobs DG, Kopans B, Reizes JM. Reevaluation of depression: what the general practitioner needs to
know. Mind/Body Med.1995;1:17-22.
Magruder KM, Norquist GS, Feil MB, Kopans B, Jacobs D. Who comes to a voluntary depression screening program? Am J Psychiatry.1995;152:1615-1622.
Greenfield SF, Reizes JM, Magruder KM, Meunz LR, Kopans B, Jacobs D. Effectiveness of community-based screening for depression. Am J Psychiatry.1997;154:1391-1397.
Jacobs DG. National Depression Screening Day: educating the public, reaching those
in need of treatment, and broadening professional understanding. Harv Rev Psychiatry.1995;3:156-159.
Baer L, Jacobs DG, Meszler-Reizes J.
et al. Development of a brief screening instrument: the HANDS. Psychother Psychosom.2000;69:35-41.
Shneidman ES. Definition of Suicide. New York, NY: Wiley; 1985.
Havens LL. Excerpts from an academic conference and recognition of suicidal risks
through the psychological examination. In: Jacobs DG, ed. The Harvard Medical School Guide
to Suicide Assessment and Intervention. San Francisco, Calif: Jossey-Bass
Publishers; 1999.
Miller MC. Suicide assessment in the primary care setting. In: Jacobs DG, ed. The Harvard Medical School Guide
to Suicide Assessment and Intervention. San Francisco, Calif: Jossey-Bass
Publishers; 1999:520-539.
Barber ME, Marzuk PM, Leon AC, Portera L. Aborted suicide attempts: a new classification of suicidal behavior. Am J Psychiatry.1998;155:385-389.
Simon RI. Clinical risk management of the suicidal patient. In: Simon RI, ed. Clinical Psychiatry and the Law. Washington, DC: American Psychiatric Press; 1992.
Blumenthal SJ. Suicide: a guide to risk factors, assessment, and treatment of suicidal
patients. Med Clin North Am.1988;72:937-971.
Narrow WE, Regier DA, Rae DS.
et al. Use of services by persons with mental and addictive disorders: findings
from the National Institute of Mental Health Epidemiologic Catchment Area
Program. Arch Gen Psychiatry.1993;50:95-107.
Not Available. Depression in Primary Care Detection and Diagnosis 1: Clinical
Practice Guideline Number 5. Rockville, Md: Agency for Health Care Policy and Research, US Dept
of Health and Human Services; 1993. AHCPR publication No. 93-0550.
Jamison KR. Night Falls Fast: Understanding Suicide. New York, NY. Alfred A Knopf Inc; 1999.
Baldessarini RJ. Antisuicidal effect of lithium treatment in major mood disorders. In: Jacobs DG, ed. The Harvard Medical School Guide
to Suicide Assessment and Intervention. San Francisco, Calif: Jossey-Bass
Publishers; 1999:355-371.
Salzman C. Treatment of the suicidal patient with psychotropic drugs and ECT. In: Jacobs DG, ed. The Harvard Medical School Guide
to Suicide Assessment and Intervention. San Francisco, Calif: Jossey-Bass
Publishers; 1999:372-382.
Tollefson GD, Rampey AH, Beasley CM.
et al. Absence of a relationship between adverse events and suicidality during
pharmacotherapy for depression. J Clin Psychopharmacol.1994;14:163-169.
Fava M, Rosenbaum JF. Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry.1991;52:108-111.
Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant
schizophrenia: impact on risk-benefit assessment. Am J Psychiatry.1995;152:183-190.
Drake RE, Gates C, Whitaker A, Cotton PG. The suicidal schizophrenic. In: Jacobs DG, Brown H, eds. Suicide: Understanding
and Responding, Harvard Medical School Perspectives. Madison, Conn:
International Universities Press Inc; 1989:183.